| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

Email Newsletters

Sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.




Show commenting policy

Most-Read Stories

  1. Unsung backups provide boost for Steelers defensive line
  2. Penguins lose hard-fought game to Blue Jackets in overtime
  3. Former Pirates pitcher Happ agrees to $36 million, 3-year deal with Blue Jays
  4. Starkey: Flashback Friday for Pitt
  5. Pitt falls flat in finale loss to Miami
  6. Body found in Allegheny River in Harrison
  7. Unabashed church pastors put politics front and center
  8. Contractor eyes early finish to work on New Stanton interchange of Interstate 70
  9. Gilbert, son of ex-Pitt football standout, commits to Panthers
  10. Run game needed for balance vs. Seahawks
  11. Police: 3 killed, 9 wounded in attack at Colorado Planned Parenthood